Ki-Ho Lee1. 1. Department of Biochemistry and Molecular Biology, College of Medicine, Eulji University, Daejeon 301-746, Korea.
Abstract
Direct communication between neighboring cells through connexin (Cx)-based gap junction is a crucial biolo-gical manner to regulate functions of a tissue consisting of multi-cell types. The present research evaluated expressional changes of Cx isoforms in the caput epididymis of adult rat exposed to estradiol benzoate (EB) or flutamide (Flu) at the early postnatal age. A single subcutaneous administration of EB at a low-dose [0.015 µg /kg body weight (BW)] or a high-dose (1.5 µg/kg BW) or Flu at a low-dose (500 µg/kg BW) or a high-dose (5 mg/kg BW) was performed to an animal at 1 week of age. Quantitative real-time PCR analysis was employed to determine expressional changes of Cx isoforms. The transcript levels of Cxs30.3 and 37 were decreased by a low-dose EB treatment, while decreases of Cxs31, 31.1, 32, 40, and 45 transcript levels were observed with a low-dose EB treatment. The treatment of a high-dose EB resulted in expressional reduction of Cxs30.3, 31, 31.1, 37, 40, 43, and 45. The Flu treatment at a low dose caused increases of Cxs26, 37, and 40 transcript levels but decreases of Cxs31.1, 43, and 45 transcript levels. Increases of Cxs30.3, 31, 37, and 40 mRNA amounts were induced by a high-dose Flu treatment. However, exposure to a high-dose Flu produced expressional decreases of Cxs31.1, 32, and 43 in the adult caput epididymis. These observations suggest that exposure to EB or Flu at the neonatal period could lead to aberrant expression of Cx isoforms in the adult caput epididymis.
Direct communication between neighboring cells through connexin (Cx)-based gap junction is a crucial biolo-gical manner to regulate functions of a tissue consisting of multi-cell types. The present research evaluated expressional changes of Cx isoforms in the caput epididymis of adult rat exposed to estradiol benzoate (EB) or flutamide (Flu) at the early postnatal age. A single subcutaneous administration of EB at a low-dose [0.015 µg /kg body weight (BW)] or a high-dose (1.5 µg/kg BW) or Flu at a low-dose (500 µg/kg BW) or a high-dose (5 mg/kg BW) was performed to an animal at 1 week of age. Quantitative real-time PCR analysis was employed to determine expressional changes of Cx isoforms. The transcript levels of Cxs30.3 and 37 were decreased by a low-dose EB treatment, while decreases of Cxs31, 31.1, 32, 40, and 45 transcript levels were observed with a low-dose EB treatment. The treatment of a high-dose EB resulted in expressional reduction of Cxs30.3, 31, 31.1, 37, 40, 43, and 45. The Flu treatment at a low dose caused increases of Cxs26, 37, and 40 transcript levels but decreases of Cxs31.1, 43, and 45 transcript levels. Increases of Cxs30.3, 31, 37, and 40 mRNA amounts were induced by a high-dose Flu treatment. However, exposure to a high-dose Flu produced expressional decreases of Cxs31.1, 32, and 43 in the adult caput epididymis. These observations suggest that exposure to EB or Flu at the neonatal period could lead to aberrant expression of Cx isoforms in the adult caput epididymis.
Entities:
Keywords:
Caput epididymis; Connexin isoform; Estradiol benzoate; Flutamide; Gap junction; Real-time PCR
The interaction between neighboring cells present in a multicellular tissue is
chiefly achieved by three junctions, including tight junction, adherens junction,
and gap junction (Lawrence et al., 1978). Of
these junctions, gap junction involves in the direct cell-cell communication through
the reciprocal exchange of materials, such as signaling molecules, ions, and small
metabolites, between cells (Lawrence et al.,
1978; Valiunas et al., 2005). A
complex of six connexin (Cx) subunits consists of a gap junctional
channel, called a connexon, and there are at least 21 Cx isoforms
identified in vertebrates (Goodenough & Paul,
2009). Even though some types of Cx isoforms are widely
present in various tissues, the expression of other Cx isoforms is
relatively restricted in certain cells (Meşe et al.,
2007). In addition, the co-expression of multiple Cx
isoforms within a single cell is frequently observed, including testis and
epididymis of the male reproductive tract (Meşe et
al., 2007).The excurrent duct of male reproductive tract includes the efferent ductules,
epididymis, and vas deferens. The epididymis is the site in which spermatozoa
released from the testis become mature and acquire fertilizing capacity (Robaire & Hermo, 1988). Histologically, the
epididymis is a tubular structure having a lumen inside surrounded by a layer of
epithelial cells (Robaire & Hermo, 1988).
The epithelial cell layer is consisted of several types of cells, including
principal, basal, narrow, and apical cells which have special morphological features
and functions distinguishable from each other (Robaire & Hermo, 1988). In addition, the proportion of cell types
present in the epididymal epithelial layer varies along the epididymal duct (Robaire & Hermo, 1988). Based on its
structure and functions, the epididymis is divided into four different parts,
initial segment, caput epididymis, corpus epididymis, and caudal epididymis (Robaire & Hermo, 1988). For example, the
epithelium of caput epididymis is thicker than that of caudal epididymis (Robaire & Hermo, 1988). Also, the caput and
corpus epididymis are histochemically specialized for luminal fluid absorption and
secretion involved in sperm maturation, while the caudal epididymis is adapted for
storage of sperm (Robaire & Hermo, 1988).
Thus, it is generally considered that different compositions of epithelial cells
would contri–bute to the regional difference of the epididymis, at least in part
(Robaire et al., 2006).The expression and presence of Cx isoforms in the epididymis during
postnatal development have been examined by several previous researches (Cyr et al., 1996; Dufresne et al., 2003; Han & Lee,
2013; Lee, 2013). It is generally
agreed that the expression of Cx isoforms in the epididymis follows
the age-specific and segmental-specific manners (Dufresne et al., 2003; Han & Lee,
2013; Lee, 2013). For example, the
highest expression of Cx26 in the caput epididymis is found at 5
months of age (Han & Lee, 2013), while the
expression of Cx26 in the corpus epididymis becomes increased until
25 days of age, followed by a gradual decrease of Cx26 expression
as aged (Lee, 2013). On the other hand, the
expression of Cx26 in the caudal epididymis during postnatal
development increases as aged and reaches the highest level at 2 years of age (Lee, 2013). However, even though expressional
patterns of Cx isoforms in the epididymis are relatively
well-documented, the cellular localization and expressional regulation of
Cx isoforms in the epididymis have not been studied in detail.
A significant decrease of Cx43 expression in the epididymis, except
the caudal epididymal part, has been observed by propylthiouracil-induced
hypothyroidism at the neonatal age (St-Pierre et
al., 2003). In addition, our previous researches have shown that
expression of Cx isoforms in the corpus and caudal epididymis at
the adult is modulated by exogenous treatments of estradiol benzoate (EB), a potent
estrogen agonist, or flutamide (Flu), an antiandrogenic compound, at the neonatal
age (Lee, 2015; Lee, 2016). These observations suggest that expression of
Cx isoforms in the epididymis is regulated by intrinsic and/or
exogenous compounds in a complicate manner. Yet, the effect of EB or Flu treatment
on the expression of Cx isoforms in the caput epididymis has not
been tested. Thus, in the present study, the expressional changes of
Cx isoforms in the adult caput epididymis after the neonatal
exposure to EB or Flu were examined at the transcript level.
MATERIALS AND METHODS
1. Experimental animals and design
Male pup rats were obtained from the delivery of pregnant Sprague Dawley rats
acquired from Samtako (Osan, Korea). Once the arrival, each pregnant rat was
individually separated and randomly designated to one of experimental groups, a
control group (peanut oil), a low-dose estradiol benzoate treatment group [EB-L,
0.015 µg of EB/kg body weight (BW)], a high-dose EB treatment group (EB-H, 1.5
µg of EB/kg BW), a low-dose flutamide treatment group (Flu-L, 500 µg of Flu/kg
BW), or a high-dose Flu treatment group (Flu-H, 5 mg of Flu/kg BW). Free access
to drinking water and food for animals were permitted for whole experimental
period.A subcutaneous injection of peanut oil for control group or pre-made EB or Flu
solution for treatment groups was performed to an experimental animal at 1 week
of age. The EB or Flu powder purchased form Tokyo Chemical Industry Co. (Tokyo,
Japan) was dissolved in 100% EtOH, and the EB or Flu solution was then diluted
in peanut oil to make working solution. An adequate amount of EB or Flu solution
to be administrated was calculated from body weight measured at 1 week of age.
The maximum volume of the injected solution per animal was not over 0.05 mL. The
number of animals utilized for the present study is as following; control group
(n=6), EB-L group (n=6), EB-H group (n=6), Flu-L group (n=6), and Flu-H group
(n=6). The present study was carried out in accordance with the guide for the
care and use of laboratory animals of National Research Council in S. Korea.
2. Procedures of tissue collection and total RNA extraction
Once the animal became 4 months of postnatal age, anesthetization by
CO2 stunning was performed. The male reproductive tract was taken
out from an incision on lower abdomen and was placed on the cold PBS solution.
The epi–didymis was first separated from the testis and other reproductive tract
and was further dissected into different epidi–dymal segments, including caput
epididymis. The tissue was briefly washed in fresh cold PBS solution once and
was quickly frozen in liquid nitrogen. The tissue was kept in –80℃ until
utilized for total RNA isolation.To extract total RNA from the caput epididymis, the frozen tissue was completely
homogenized in total RNA extraction solution (iNtRON Biotech, Sungnam, Korea).
Total RNA was precipitated by isopropanol, and total RNA pellet was washed with
70% DEPC-EtOH. Then, air-dried total RNA was dissolved in DEPC- dH2O.
The concentration of total RNA was assessed with NanoDrop Lite spectrophotomer
(Thermo Scientific, Wilmington, DE). The quality of total RNA was evaluated by
conventional agarose gel electrophoresis.
3. Construction of cDNA from total RNA and performance of quantitative
real-time PCR
The first-stranded cDNA was generated with 1 µg of total RNA, oligo-dT primer,
and ImProm-IITM reverse transcription system (Promega, Madision, WI)
in a total volume of 20 µL. The reverse transcription reaction was carried out
in a serial process of 25℃ for 5 min, 42℃ for 90 min, and 70℃ for 15 min. The
cDNA construction was used for quantitative real-time PCR analysis as below.
Oligonucleotide primers utilized for quantitative real-time PCR analysis are
listed in Table 1.
Table 1
Oligonucleotide primers for real-time PCR analysis
Cx : connexin; Ppia :
peptidylprolyl isomerase A (cyclophilin A).
Cx : connexin; Ppia :
peptidylprolyl isomerase A (cyclophilin A).One microliter of cDNA, in addition to 10 pmol primer set, 10 µL PCR master
mixture (Finnzymes, Espoo, Finland), and DNase-free dH2O, was used to
conduct the quantitative real-time PCR. The mixture of PCR in a total volume of
20 µL was placed in a thermocycler (Bio-Rad Laboratories, Hercules, CA) and was
undergone a sequential procedure as followings; a pre-denaturation step at 95℃
for 30 sec, 40 cycles of denaturation at 95℃ for 30 sec, annealing at
Tm for 30 sec, and extension at 72℃ for 30 sec, and an additional
extension step at 72℃ for 5 min. For a quality control purpose of PCR,
cyclophilin A (Ppia) was included in every reaction.
4. Statistical Analysis and Presentation of Data
For each experimental group, independently quadruplicated RT reactions and PCRs
were performed to obtain a mean and a standard error. The experimental data were
presented in the relative expressional ratio between Ppia and
Cx isoform. Statistical significances of
Cx expression between control and EB or Flu treatment
groups were evaluated by one-way ANOVA, followed by Duncan’s test. If
P is less than 0.05, it was regarded as the existence of
statistical difference among experimental groups.
RESULTS
1. Expression of Cx26 and Cx30.3 in the
Adult caput epididymis of rat exposed to EB or flutamide at 1 week of postnatal
age
The treatment of EB at 1 week of age didn’t influence on gene expression of
Cx26 in the adult caput epididymis (Fig. 1A). However, a significant increase of
Cx26 transcript level was observed with a low-dose Flu
treatment, even though expression of Cx26 was not significantly
changed by a high-dose Flu treatment (Fig.
1A).
Fig. 1
Changes of Cx26 and Cx30.3
transcript levels in the caput epididymis of the adult rat exposed to
estradiol benzoate (EB) or flutamide (Flu) at 1 week of postnatal
age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx26 (A) or Cx30.3 (B) were
present in different letters.
Changes of Cx26 and Cx30.3
transcript levels in the caput epididymis of the adult rat exposed to
estradiol benzoate (EB) or flutamide (Flu) at 1 week of postnatal
age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx26 (A) or Cx30.3 (B) were
present in different letters.Expression of Cx30.3 was significantly increased by a low-dose EB treatment,
while a reduction of Cx30.3 transcript level was detected by a high-dose EB
treatment (Fig. 1B). The treatment of a
low-dose Flu at 1 week of age didn’t affect the expression of Cx30.3 in the
adult caput epididymis (Fig. 1B). However,
a tremendous increase of Cx30.3 transcript amount in the caput epididymis at the
adult was observed with a high-dose Flu treatment at 1 week of age (Fig. 1B).
2. Expression of Cx31 and Cx31.1 in the
adult caput epididymis of rat exposed to EB or flutamide at 1 week of postnatal
age
Expression of Cx31 in the adult caput epididymis was
significantly decreased by a low-dose EB treatment (Fig. 2A). An additional reduction of Cx31
transcript level was observed in a high-dose EB-treated group, as shown in Fig. 2A. There was no change of
Cx31 transcript amount by a lowdose Flu treatment, but a
significant increase of Cx31 expression was detected in a
high-dose Flu-treated group (Fig. 2A). The
expression of Cx31.1 isoform in the adult caput epididymis was
declined in all treatment groups (Fig. 2B).
The EB treatment resulted in a significant decrease of Cx31.1
transcript level, even though there was no significant difference on
Cx31.1 expression between two doses (Fig. 2B). The Flu treatment also caused significant
reduction of Cx31.1 transcript level, but the effect of Flu
treatment on Cx31.1 expression was more severe with a low-dose
treatment than a high-dose treatment (Fig.
2B).
Fig. 2
Changes of Cx31 and Cx31.1
transcript levels in the caput epididymis of the adult rat exposed to
estradiol benzoate (EB) or flutamide (Flu) at 1 week of postnatal
age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx31 (A) or Cx31.1 (B) were
present in different letters.
Changes of Cx31 and Cx31.1
transcript levels in the caput epididymis of the adult rat exposed to
estradiol benzoate (EB) or flutamide (Flu) at 1 week of postnatal
age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx31 (A) or Cx31.1 (B) were
present in different letters.
3. Expression of Cx32 and Cx37 in the adult
caput epididymis of rat exposed to EB or flutamide at 1 week of postnatal
age
The expression of Cx32 in the adult caput epididymis after the
exposure to EB at 1 week of age was significantly decreased by a low-dose
treatment, but not by a high-dose treatment (Fig.
3A). On the other hand, the treatment of a low-dose Flu didn’t affect
the expression of Cx32, but a significant decline of
Cx32 transcript level was detected with a high-dose Flu
treatment (Fig. 3A).
Fig. 3
Changes of Cx32 and Cx37 transcript
levels in the caput epididymis of the adult rat exposed to estradiol
benzoate (EB) or flutamide (Flu) at 1 week of postnatal age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx32 (A) or Cx37 (B) were present
in different letters.
Changes of Cx32 and Cx37 transcript
levels in the caput epididymis of the adult rat exposed to estradiol
benzoate (EB) or flutamide (Flu) at 1 week of postnatal age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx32 (A) or Cx37 (B) were present
in different letters.The effect of EB or Flu treatment at 1 week of age on the expression of
Cx37 in the adult caput epididymis is shown in Fig. 3B. The treatment of a low-dose EB
resulted in a significant increase of Cx37 expression, but a
high-dose EB treatment caused a decrease of Cx37 transcript
level (Fig. 3B). Exposure to a low-dose Flu
at 1 week of age led into a major increase of Cx37 expression
in the adult caput epididymis, and a further rise of Cx37
transcript level was induced by a high-dose Flu treatment (Fig. 3B).
4. Expression of Cx40, Cx43, and
Cx45 in the adult caput epididymis of rat exposed to EB or
flutamide at 1 week of postnatal age
Expression of Cx40 in the adult caput epididymis was
significantly down-regulated by the treatment of EB at 1 week of age, even
though the level of Cx40 transcript was not statistically
different between a low-dose and a high-dose EB treatment (Fig. 4A). However, the Flu treatment at a low-dose resulted
in a significant increase of Cx40 transcript levels (Fig. 4A). The treatment of a high-dose Flu
induced an additional surge of Cx40 expressional level, as
shown in Fig 4A.
Fig. 4
Changes of Cx40, Cx43, and
Cx45 transcript levels in the caput epididymis of
the adult rat exposed to estradiol benzoate (EB) or flutamide (Flu) at 1
week of postnatal age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx40 (A), Cx43 (B), or
Cx45 (C) were present in different letters.
Changes of Cx40, Cx43, and
Cx45 transcript levels in the caput epididymis of
the adult rat exposed to estradiol benzoate (EB) or flutamide (Flu) at 1
week of postnatal age.
Subcutaneous injection of EB at a low dose (0.015 mg/kg body weight,
EB-L) or a high dose (1.5 mg/kg body weight, EB-H) or Flu at a low dose
(500 mg/kg body weight, Flu-L) or at a high dose (50 mg/kg body weight,
Flu-H) was carried out at 1 week of age. Peanut oil was administrated
into control group (Cont). Statistical differences among control and
experimental groups in EB or Flu treatment group on transcript levels of
Cx40 (A), Cx43 (B), or
Cx45 (C) were present in different letters.Expression of Cx43 in the caput epididymis was not affected by a
low-dose EB treatment (Fig. 4B). But, a
significant decrease of Cx43 transcript level was observed with
a high-dose EB treatment (Fig. 4B). The
treatment of Flu caused the reduction of Cx43 transcript level,
although there was no significant difference on the expression of
Cx43 between the treatments at a low-dose and a high-dose
Flu (Fig. 4B).The transcript level of Cx45 was significantly decreased by a
low-dose EB treatment, as seen in Fig. 4C.
The treatment of a high-dose EB also caused the reduction of
Cx45 transcript level (Fig.
4C). However, the abundance of Cx45 transcript in a
high-dose EB treatment group was higher than that in a low-dose EB treatment
group (Fig. 4C). A low-dose Flu treatment
led into a significant decrease of Cx45 expression in the adult
caput epididymis, even though a high-dose Flu treatment didn’t cause a change of
Cx45 transcript level (Fig.
4C).
DISCUSSION
Expressional alternation of Cx isoforms in the adult corpus and
caudal epididymis by EB or Flu treatment at neonatal age has been previously
examined (Lee, 2015; Lee, 2016). The current research has investigated the effect of
EB or Flu treatment at 1 week of postnatal age on the expression of
Cx isoforms in the caput epididymis at the adult. The findings
are summarized as follows: (1) the exposure to EB at a low dose results in
significant decreases of the expression of most Cx isoforms in the
caput epididymis, except Cx30.3 and Cx37 which the
expression has become increased and Cx26 and Cx43
with no significant expressional changes: (2) the treatment of EB at a high dose at
1 week of postnatal age generally causes significant decreases of most
Cx isoforms in the caput epididymis at the adult, but not
Cx26 and Cx32 showing no significant change of
the expressional level: (3) the effect of a low-dose Flu treatment leads to
increases of Cx37 and Cx40 expression, decreases
of Cx31.1, Cx43, and Cx45
expression, and no expressional change of Cx26,
Cx30.3, Cx31, and Cx32: and (4)
the administration of a high-dose Flu at 1 week of age results in significant
expressional increases of Cx30.3, Cx31,
Cx37, and Cx40 and significant expressional
decreases of Cx31.1, Cx32, and
Cx43 in the adult caput epididymis.It is well known that the epididymis is a representative androgen-responsive tissue
in the male reproductive tract (Robaire &
Hinton, 2006). Testosterone and dihydrotestosterone play important roles
on the proper differentiation and maturation of the epididymis (Robaire & Hinton, 2006). However, Atanassova et al (2001) have demonstrated that
expression of estrogen receptor α (ERα) in the epididymis is segmental-specific and
postnatal age-specific. Also, others have shown the aberrant gene expression in the
epididymis of the adult after the exposure to EB during neonatal period (Putz et al., 2001). Moreover, Gorowska et al (2014) have found aberrant gene
expression in the epididymis exogenously treated with steroidal and/or
anti-steroidal compounds. Thus, these findings suggest that the epididymis could be
a target tissue of not only androgen but also estrogen. Indeed, our previous
researches have also shown abnormal expression of Cx isoforms in
the adult corpus and caudal epididymis exposed with EB or Flu at the neonatal age
(Lee, 2015; Lee, 2016). However, it seems that expressional regulation of
Cx isoforms in different epididymal parts does not fit into a
uniformed manner. For instance, with a low-dose EB treatment at 1 week of age, there
is no expressional change of Cx43 in the caput epididymis of the
adult. But, in the same circumstance, expression of Cx43 is greatly
increased in the corpus epididymis, but not in caudal epididymis (Lee, 2015; Lee,
2016). In addition, even though the treatment of a low-dose Flu at 1 week
of age causes a significant increase of Cx32 expression in the
adult caput epididymis, the same treatment does not give an influence on the
expression of Cx32 in adult corpus and caudal epididymis (Lee, 2015; Lee,
2016). Due to the complexity of data obtained, it is hard to conclude the
role of estrogen and/or androgen on the expression of each Cx
isoform in the epididymis at this point. But, it seems to be clear that exogenous
exposure to EB or Flu at the early postnatal age affects the expression of Cx
isoforms in the entire epididymal segments. Also, it is likely that the expressional
regulation of Cx isoform by androgenic and/or estrogenic substances
is segmental-specific in the epididymis. Like promoter assay and gene expression
analysis, detailed molecular approaches would provide valuable information to
explain differential expressional regulation of each Cx isoform at
the different epididymal parts.The expression of androgen receptor (AR) and ER in the epididymis during postnatal
development is fluctuated and shows segmental-specific patterns (Atanassova et al., 2001; You & Sar, 1998). Additionally, until 14 days of postnatal
age, the differentiation of epithelial cells in the epididymis does not begin (Robaire et al., 2006). At the 3th week of
postnatal age, columnar cells are derived from undifferentiated epithelial cells,
and the columnar cell becomes either the basal or principal cell around 4th week of
postnatal age (Robaire et al., 2006). The
appearance of other cell types, including narrow and clear cells, start after 35
days of postnatal age (Robaire et al., 2006).
Because the postnatal maturation of the epididymis is dependent on androgenic and/or
other various hormonal factors, any elements affecting hormonal homeostasis during
the early postnatal period could give an influence on the differentiation of the
epithelial cell in the epididymis and furthermore numbers of epithelial cell types
in the adult epididymis. Cyr et al (1996) have
demonstrated the limited localization of Cx43 between basal and
principal cells, but not between adjacent principal cells. Thus, if EB or Flu
treatment at 1 week of postnatal age influences on the differentiation of the
epithelial cells in the epididymis, it is supposed that the proportion of epithelial
cell types in the caput epididymis at the adult would be changed and thus the
expression of Cx isoforms, including Cx43, would
be altered.In conclusion, based on previous and present findings, the expression of
Cx isoforms in the epididymis is differentially regulated in
segment-specific manner. Even though a precise regulatory mechanism of expression of
Cx isoforms in the epididymis has not been provided, it is
evident that the exposure to estrogenic and/or anti-androgenic substance during the
early postnatal development could impact on the expression of normal expression of
Cx isoforms in the adult epididymis and presumably epididymal
functions at the adult.
Authors: N Atanassova; C McKinnell; K Williams; K J Turner; J S Fisher; P T Saunders; M R Millar; R M Sharpe Journal: Endocrinology Date: 2001-02 Impact factor: 4.736